Concepedia

Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT

Sebastian Bauer, Christopher L. Corless, Michael C. Heinrich, Olaf Dirsch, Gerald Antoch, Jörg Kanja, S. Seeber, J. Schütte

Cancer Chemotherapy and Pharmacology · 2003 · 70 citations · 5 references

DOI

Concepts

References

5

Gain-of-Function Mutations of c- <i>kit</i> in Human Gastrointestinal Stromal Tumors

Seiichi Hirota, Koji Isozaki, Y Moriyama et al. · Science · 1998 · 4.5K citations

, , +17

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri, Margaret von Mehren, Charles D. Blanke et al. · New England Journal of Medicine · 2002 · 4.4K citations · Full text

, , +14

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

Allan T. van Oosterom, Ian Judson, Jaap Verweij et al. · The Lancet · 2001 · 1.3K citations

, , +12

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

Brian P. Rubin, Samuel Singer, C. Tsao et al. · PubMed · 2001 · 969 citations

, , +17

KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size

Christopher L. Corless, Laura McGreevey, Andrea Haley et al. · American Journal Of Pathology · 2002 · 444 citations · Full text

, , +12